Paul Thomas insider trades
Open-market stock purchases and sales by Paul Thomas, Director at Axogen, Inc, from SEC Form 4 filings since Jul 26, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | AXGN Axogen, Inc | Bought (not open market) | — |
| Jun 19, 2026 | AXGN Axogen, Inc | Bought (not open market) | — |
| Jun 9, 2026 | TELA TELA Bio, Inc | Bought (not open market) | — |
| Jun 9, 2026 | TELA TELA Bio, Inc | Bought (not open market) | — |
| Jun 9, 2026 | TELA TELA Bio, Inc | Bought (not open market) | — |
| Jun 9, 2026 | TELA TELA Bio, Inc | Bought (not open market) | — |
| Dec 9, 2025 | AXGN Axogen, Inc | Sold | $634K |
Companies traded
- AXGN Axogen, Inc: 1 sale, last Jun 24, 2026
- TELA TELA Bio, Inc: other filings, last Jun 9, 2026
- NASD Abiomed Inc: 1 sale, last Dec 22, 2022
- SRGA Surgalign Holdings, Inc: other filings, last Aug 15, 2022
- ABMD Abiomed Inc: 10 sales, last Aug 18, 2021
- RTIX RTI Surgical Holdings, Inc: other filings, last Feb 26, 2020
- AEGR Aegerion Pharmaceuticals, Inc: other filings, last Nov 29, 2016
- ROKA Roka BioScience, Inc: 2 buys, last Nov 10, 2016
- VITA Orthovita Inc: other filings, last Jun 27, 2011